Veterinary Medicines

Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs

Authorised
  • Sodium glycerophosphate pentahydrate
  • Magnesium chloride hexahydrate
  • CALCIUM GLUCONATE FOR INJECTION
Download as PDF

Produktidentifikation

Lægemidlets navn:
Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs
Kaltetan forte 458,4 mg/1 ml + 125 mg/1 ml + 20 mg/ml Roztwór do infuzji
Aktiv substans:
Dyrearter:
  • Hest
  • Kvæg
  • Svin
Administrationsvej:
  • Intravenøs anvendelse

Produktoplysninger

Aktiv substans / Styrke:
  • Kun tilgængelig på English
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Kun tilgængelig på English
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Kun tilgængelig på English
    458.40
    milligram(s)
    /
    1.00
    millilitre(s)
Lægemiddelform:
  • Infusionsvæske, opløsning
Withdrawal period by route of administration:
  • Intravenous use
    • Hest
      • Milk
        5
        week
    • Kvæg
      • Meat and offal
        5
        week
    • Svin
      • Meat and offal
        5
        week
Anatomisk terapeutisk kemisk veterinær (ATCvet) kode:
  • QA12AX
Udleveringsbestemmelse:
Godkendelsesstatus:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Pakningsbeskrivelse:

Yderligere oplysninger

Entitlement type:
Lovgrundlag for godkendelse:
Indehaver af markedsføringstilladelsen:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Produktionssteder for batchfrigivelse:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Ansvarlig myndighed:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Markedsføringstilladelsesnummer:
  • 3172
Dato for ændring af godkendelsesstatus:
Referencemedlemsstat:
Procedurenummer:
  • PL/V/0110/002
Berørte medlemsstater:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."